Krystal Biotech Overview
Krystal Biotech Target Price
Analysts' 12-month price predictions for KRYS.
Get informed when a big investor buys or sells
+ FollowShare Price
$375.07
Average Target Price
$330.50
11.9% downside
11.9% downside2 analysts in the last 4 months
High: $361 | Low: $300
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-16 | H.C. WainwrightJoseph Pantginis | $361 | 3.8% downside |  |
| 2026-05-05 | Evercore ISI | $300 | 20% downside | |
| 2026-02-18 | Chardan CapitalGeulah Livshits | $323 | 13.9% downside | |
| 2026-02-17 | JefferiesRoger Song | $371 | 1.1% downside | |
| 2026-01-30 | Goldman Sachs | $327 | 12.8% downside | |
| 2026-01-09 | H.C. Wainwright | $310 | 17.3% downside | |
| 2025-10-17 | GuggenheimDebjit Chattopadhyay | $224 | 40.3% downside | |
| 2025-08-22 | Chardan Capital | $216 | 42.4% downside | |
| 2024-09-11 | Stifel NicolausDae Gon Ha | $220 | 41.3% downside | |
| 2024-09-02 | Bank of America SecuritiesAlec Stranahan | $205 | 45.3% downside | |
| 2024-08-12 | Evercore ISIGavin Clark-Gartner | $206 | 45.1% downside | |
| 2024-04-15 | Stifel NicolausDae Gon Ha | $204 | 45.6% downside | |
| 2022-11-07 | Chardan CapitalGeulah Livshits | $133 | 64.5% downside | |
| 2022-08-08 | Chardan CapitalGeulah Livshits | $130 | 65.3% downside | |